Brief: Active Biotech receives waiver from bank commitment, expires on Feb 27

Active Biotech AB publ

20/12/2017 14:00

Dec 20 (Reuters) - Active Biotech AB  ACTI.ST : 
    * REG-ACTIVE BIOTECH PROVIDES UPDATED INFORMATION ABOUT THE 
COMPANY'S FINANCIAL POSITION 
    * SAYS HAS RECEIVED A WAIVER (EXEMPTION) FROM ITS 
COMMITMENT TO 
BANK THAT FINANCES COMPANY'S PROPERTY IN LUND THAT COMPANY'S 
LIQUIDITY SHOULD NEVER FALL BELOW SEK 30 MILLION 
    * SAYS THIS EXEMPTION APPLIES UNTIL AND INCLUDING FEBRUARY 
27, 
2018 
    * SAYS EXEMPTION APPLIES UNTIL AND INCLUDING FEBRUARY 27, 
2018, 
DURING WHICH TIME COMPANY MUST PRODUCE A SALE OF PROPERTY AT A 
VALUE THAT GENERATES A LIQUIDITY SUPPLEMENT THAT MEETS 
REQUIREMENTS FOR GOING CONCERN 
    * SAYS UNLESS THIS OR ANY OTHER SOLUTION IS FOUND BEFORE 
FEBRUARY 
27, 2018, COMPANY WILL NOT HAVE FUNDING FOR COMING TWELVE-MONTH 
PERIOD 
 
Source text for Eikon:  ID:nGNEbwckcK  
Further company coverage:  ACTI.ST  
 
 (Stockholm Newsroom) 
 ((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))